In spring 1923 we were formed after our founders made a trip to the U.S. and investigated a new form of diabetes treatment, We now have the broadest diabetes product portfolio in the industry. We also have a leading position in areas such as haemostasis management, growth hormone therapy and hormone replacement therapy.

Please quote eSources UK when contacting us.